Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.

Saved in:
Bibliographic Details
Title: Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.
Authors: Ji L; Peking University People's Hospital, Beijing, China., Liu Y; Yancheng First People's Hospital, Yancheng, China., Miao H; The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China., Xie Y; Pingxiang People's Hospital, Pingxiang, China., Yang M; Pfizer (China) R&D Co., Shanghai, China., Wang W; Pfizer (China) R&D Co., Shanghai, China., Mu Y; Pfizer (China) R&D Co., Shanghai, China., Yan P; Pfizer (China) R&D Co., Shanghai, China., Pan S; Pfizer Inc., New York, New York., Lauring B; Merck & Co., Inc., Kenilworth, New Jersey., Liu S; MSD China, Beijing, China., Huyck S; Merck & Co., Inc., Kenilworth, New Jersey., Qiu Y; MSD China, Beijing, China., Terra SG; Pfizer Inc., Andover, Massachusetts.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Jun; Vol. 21 (6), pp. 1474-1482. Date of Electronic Publication: 2019 Apr 05.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1463-1326
DOI:10.1111/dom.13681